No Data
No Data
The Five-year Loss for Guanhao BiotechLtd (SZSE:300238) Shareholders Likely Driven by Its Shrinking Earnings
Optimistic Investors Push Guanhao Biotech Co.,Ltd. (SZSE:300238) Shares Up 28% But Growth Is Lacking
Guan Hao Biology: Summary of the 2024 Semi-Annual Report
Guan Hao Biology: 2024 Semi-Annual Report
guanhao biotech (300238.SZ): net income in the first half of the year was 20.148 million yuan, a year-on-year decrease of 34.46%.
Guanhao Biotech (300238.SZ) announced its semi-annual report, with revenue of 0.19 billion yuan, a decrease of 10.02% year-on-year, net income of 20.148 million yuan, a decrease of 34.46% year-on-year, non-GAAP net income of 18.92 million yuan, a decrease of 31.33% year-on-year, and basic earnings per share of 0.08 yuan.
Guanhao Biotech (300238.SZ): The current bioartificial liver project is in the preclinical research stage.
Guanhao Biotech (300238.SZ) stated on the investor platform on August 19 that the company's bio-artificial liver project is currently in pre-clinical research stage.
No Data
No Data